Why is iron supplementation routinely restricted during the early stages of HSCT?

Why is iron supplementation routinely restricted during the early stages of HSCT?

• A. To prevent iron overload from transfusions and complications
• B. To avoid iron deficiency during recovery
• C. To reduce risk of infection by lowering iron
• D. Because iron therapy improves wound healing

Answer: (A)

In the early HSCT period, iron supplementation is avoided to prevent iron overload from transfusions and the complications that come with it. Patients often receive many red blood cell transfusions, and each unit delivers iron. The body has no efficient way to excrete excess iron, so it can accumulate in organs such as the liver and heart, as well as endocrine tissues. This iron burden can impair organ function and worsen transplant-related outcomes during a critical recovery window. While iron is important for healing, the immediate risk in this setting is overload from transfusions, not deficiency.

In the early HSCT period, iron supplementation is avoided to prevent iron overload from transfusions and the complications that come with it. Patients often receive many red blood cell transfusions, and each unit delivers iron. The body has no efficient way to excrete excess iron, so it can accumulate in organs such as the liver and heart, as well as endocrine tissues. This iron burden can impair organ function and worsen transplant-related outcomes during a critical recovery window. While iron is important for healing, the immediate risk in this setting is overload from transfusions, not deficiency.